These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28416638)

  • 1. Eya2, a Target Activated by Plzf, Is Critical for
    Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eya2 is critical for the E2A‑HLF‑mediated immortalization of mouse hematopoietic stem/progenitor cells.
    Maharjan BD; Ono R; Nosaka T
    Int J Oncol; 2019 Mar; 54(3):981-990. PubMed ID: 30628662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
    Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
    Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
    Yang WC; Shih HM
    Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
    Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
    PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [hCG-PLZF-RARA transgenic mice develop leukemia resembling human chronic myeloid leukemia].
    Meng X; Cheng G; Wang L
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):22-5. PubMed ID: 11776589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.
    Zheng X; Beissert T; Kukoc-Zivojnov N; Puccetti E; Altschmied J; Strolz C; Boehrer S; Gul H; Schneider O; Ottmann OG; Hoelzer D; Henschler R; Ruthardt M
    Blood; 2004 May; 103(9):3535-43. PubMed ID: 14739224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
    Lin S; Wei J; Wunderlich M; Chou FS; Mulloy JC
    Oncotarget; 2016 Aug; 7(35):55939-55950. PubMed ID: 27509060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.
    Steinert G; Oancea C; Roos J; Hagemeyer H; Maier T; Ruthardt M; Puccetti E
    PLoS One; 2011; 6(7):e22540. PubMed ID: 21811629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.
    Zhou J; Pérès L; Honoré N; Nasr R; Zhu J; de Thé H
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9238-43. PubMed ID: 16757557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of genome-wide PLZF/RARA target genes.
    Spicuglia S; Vincent-Fabert C; Benoukraf T; Tibéri G; Saurin AJ; Zacarias-Cabeza J; Grimwade D; Mills K; Calmels B; Bertucci F; Sieweke M; Ferrier P; Duprez E
    PLoS One; 2011; 6(9):e24176. PubMed ID: 21949697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.
    Boukarabila H; Saurin AJ; Batsché E; Mossadegh N; van Lohuizen M; Otte AP; Pradel J; Muchardt C; Sieweke M; Duprez E
    Genes Dev; 2009 May; 23(10):1195-206. PubMed ID: 19451220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
    Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
    Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
    Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
    J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
    Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
    Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.
    Lee SH; Kim J; Ryu JY; Lee S; Yang DK; Jeong D; Kim J; Lee SH; Kim JM; Hajjar RJ; Park WJ
    J Mol Cell Cardiol; 2012 Mar; 52(3):718-26. PubMed ID: 22197309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
    Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
    PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.